This contract involves the purchase and ongoing supply of pharmaceutical products used in chemotherapy for the Hospital Pharmacy. The procurement is divided into the following packages: PACKAGE 1 - PAZOPANIB, PACKAGE 2 - LEVOFOLINIC ACID, PACKAGE 3 - BEVACIZUMAB. Suppliers may offer products that ar
Tender closed on 12 Jan 2026. Awaiting award.
No single supplier dominates the field.
In healthcare medical, CLINICAL HOSPITAL OF BLESSED ANNA MAZOWIECKA has awarded 10 contracts to 10 suppliers.
+4 more suppliers
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the purchase and ongoing delivery of disposable medical and hematological equipment, divided into 9 lots. Detailed specifications and pricing information can be found in the attached form (Annex 1) related to each lot. Suppliers are invited to submit their bids for this opport
This contract involves the delivery and implementation of a system for planning, recording, and managing the working hours of both medical and non-medical staff. The system must integrate with Simple.ERP and include post-sale service support for a period of 36 months, as specified by the buyer.
This contract involves the purchase and ongoing supply of medicinal products for the Hospital Pharmacy, divided into the following packages: PACKAGE 1 - MEDICINES USED IN INFECTIONS PACKAGE 2 - AMPICILLIN + SULBACTAM PACKAGE 3 - SODIUM CHLORIDE PACKAGE 4 - LIDOCAINE HYDROCHLORIDE PACKAGE 5 - AMOXICI
This contract involves the purchase and ongoing supply of pharmaceutical products used in chemotherapy for the Hospital Pharmacy. The procurement is divided into two packages: PACKAGE 1 - Dostarlimab and PACKAGE 2 - Pembrolizumab. Suppliers may offer products that are approved for sale in Poland in
A three-year funded fellowship helping healthcare professionals with PhDs return to clinical research after extended career breaks.
MMUH seeks a dermatology service provider to help meet increased demand for dermatological care through outsourced clinical services.
Market engagement opportunity to provide input on capillary blood sampling device requirements for HSCNI Trusts; questionnaire submissions due by 14th November 2026.
Hull City Council seeks to award a £187,500 Drug and Alcohol Treatment and Recovery services contract from November 2026 to March 2029 via direct award; providers must submit representations by 27 October 2026.
